Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Science‐based innovation as systematic risk‐taking The case of new drug development

Science‐based innovation as systematic risk‐taking The case of new drug development Purpose – Research on innovation and knowledge management practice would benefit from examining science‐based innovation work, that is, innovations derived from the ability to exploit scientific know‐how, in greater detail. While much engineering innovation work may be predetermined through rational breakdown analysis, there is always a factor of chance and luck in scientific work. Scientific work is never linear and predictable but must always be envisaged as the outcome of a combination of rule‐governed activities and a certain degree of unconditioned discoveries. The purpose of this paper is to report on how practicing laboratory researchers in a major pharmaceutical company regard their innovation work as being what is always of necessity inherently indeterminate and therefore put demands on top management to allow for a reasonable amount of risk‐taking. Design/methodology/approach – Case study methodology based on interviews with 36 laboratory scientists and managers in a major pharmaceutical company. Findings – The paper concludes that innovation research and knowledge management studies need to regard science‐based innovation as a specific form of innovation not wholly capable of being managed through rationalist management control systems. Originality/value – The paper bridges studies of innovation work in pharmaceutical industry with the perception of risk‐taking among the practicing researchers. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Innovation Management Emerald Publishing

Science‐based innovation as systematic risk‐taking The case of new drug development

Alexander Styhre
European Journal of Innovation Management , Volume 9 (3): 12 – Jul 1, 2006
Download PDF
12 pages

Loading next page...
 
/lp/emerald-publishing/science-based-innovation-as-systematic-risk-taking-the-case-of-new-Mfv867oJCN

References (37)

Publisher
Emerald Publishing
Copyright
Copyright © 2006 Emerald Group Publishing Limited. All rights reserved.
ISSN
1460-1060
DOI
10.1108/14601060610678167
Publisher site
See Article on Publisher Site

Abstract

Purpose – Research on innovation and knowledge management practice would benefit from examining science‐based innovation work, that is, innovations derived from the ability to exploit scientific know‐how, in greater detail. While much engineering innovation work may be predetermined through rational breakdown analysis, there is always a factor of chance and luck in scientific work. Scientific work is never linear and predictable but must always be envisaged as the outcome of a combination of rule‐governed activities and a certain degree of unconditioned discoveries. The purpose of this paper is to report on how practicing laboratory researchers in a major pharmaceutical company regard their innovation work as being what is always of necessity inherently indeterminate and therefore put demands on top management to allow for a reasonable amount of risk‐taking. Design/methodology/approach – Case study methodology based on interviews with 36 laboratory scientists and managers in a major pharmaceutical company. Findings – The paper concludes that innovation research and knowledge management studies need to regard science‐based innovation as a specific form of innovation not wholly capable of being managed through rationalist management control systems. Originality/value – The paper bridges studies of innovation work in pharmaceutical industry with the perception of risk‐taking among the practicing researchers.

Journal

European Journal of Innovation Management – Emerald Publishing

Published: Jul 1, 2006

Keywords: Knowledge management; Innovation; Pharmaceuticals industry

There are no references for this article.